Risk of hepatitis B reactivation in rheumatic patients receiving tocilizumab treatment. Ann Med Res [Internet]. 2025 Nov. 25 [cited 2025 Dec. 2];32(11):512-7. Available from: http://www.annalsmedres.org/index.php/aomr/article/view/4880